Summit Therapeutics Inc.
SMMTNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for SMMT. That does not mean none is planned.
Get an email about SMMT's next catalysts
Track Summit Therapeutics (SMMT) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
0 upcoming, 3 past
No catalysts found.
Market Overview
Stock performance and key metrics
Ridinilazole
Clostridioides Difficile Infection
Ivonescimab Injection
Non-Small Cell Lung Cancer
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Ridinilazole | Phase 3 | Clostridioides Difficile Infection | - | - |
Ivonescimab Injection | Phase 3 | Non-Small Cell Lung Cancer | - | - |
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in Summit Therapeutics Inc.'s drug pipeline?β
CatalystAlert tracks 2 drug candidates in Summit Therapeutics Inc.'s (SMMT) pipeline across Phase 3. Its lead program is Ivonescimab Injection (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Summit Therapeutics Inc.'s next FDA catalyst?β
CatalystAlert tracks every upcoming catalyst for Summit Therapeutics Inc. (SMMT) β PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β each confidence-rated as confirmed, estimated or AI-detected.
How do I track SMMT biotech catalysts?β
Add SMMT to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Summit Therapeutics Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β sourced from ClinicalTrials.gov, FDA and SEC filings.
